Stuart Snyder

Array ( [id] => 9294534 [patent_doc_number] => 20140038168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'NOVEL DRUG TARGET SITE WITHIN GP120 OF HIV' [patent_app_type] => utility [patent_app_number] => 13/881835 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 33374 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171318 [patent_doc_number] => 20120107338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'IDENTIFICATION OF A NOVEL RETROVIRUS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA' [patent_app_type] => utility [patent_app_number] => 13/282888 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21061 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107338.pdf [firstpage_image] =>[orig_patent_app_number] => 13282888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648101 [patent_doc_number] => 08802110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines' [patent_app_type] => utility [patent_app_number] => 13/239376 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 63 [patent_no_of_words] => 38321 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13239376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9262639 [patent_doc_number] => 20130344569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'PERMANENT HUMAN CELL LINES FOR THE PRODUCTION OF INFLUENZA VIRUSES' [patent_app_type] => utility [patent_app_number] => 13/816976 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13404 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003094 [patent_doc_number] => 20130224219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'DRUG AND METHOD FOR THE PROPHYLAXIS OF HIV INFECTION AND FOR THE PROPHYLAXIS AND TREATMENT OF DISEASES CAUSED BY OR ASSOCIATED WITH HIV, INCLUDING AIDS' [patent_app_type] => utility [patent_app_number] => 13/814659 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4638 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8975972 [patent_doc_number] => 20130209402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'HUMAN PAPILLOMAVIRUS E7 ANTIGEN COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/810352 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 20520 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510052 [patent_doc_number] => 20110256165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'COMPOSITIONS OF HSP60 PEPTIDES AND VIRAL ANTIGENS FOR VACCINATION AND DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/164411 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21437 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256165.pdf [firstpage_image] =>[orig_patent_app_number] => 13164411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9970664 [patent_doc_number] => 09017668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'High affinity human antibodies to human cytomegalovirus (CMV) gB protein' [patent_app_type] => utility [patent_app_number] => 13/162497 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7171 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10850224 [patent_doc_number] => 08876903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'In vitro test system for viral infections' [patent_app_type] => utility [patent_app_number] => 13/151343 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 5786 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13151343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164911 [patent_doc_number] => 20110195078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'TAT-BASED IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR THEIR DISCOVERY AND USE' [patent_app_type] => utility [patent_app_number] => 13/087963 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12065 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195078.pdf [firstpage_image] =>[orig_patent_app_number] => 13087963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697074 [patent_doc_number] => 20110229516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'ADJUVANT PHASE INVERSION CONCENTRATED NANOEMULSION COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/043356 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9683 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229516.pdf [firstpage_image] =>[orig_patent_app_number] => 13043356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573105 [patent_doc_number] => 20110268761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition' [patent_app_type] => utility [patent_app_number] => 13/035692 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19040 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268761.pdf [firstpage_image] =>[orig_patent_app_number] => 13035692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7493723 [patent_doc_number] => 20110239331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Insecticidal Compounds and Methods for Selection Thereof' [patent_app_type] => utility [patent_app_number] => 13/013348 [patent_app_country] => US [patent_app_date] => 2011-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9212 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20110239331.pdf [firstpage_image] =>[orig_patent_app_number] => 13013348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958550 [patent_doc_number] => 20110182937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Dendritic Cell Vaccines' [patent_app_type] => utility [patent_app_number] => 13/011798 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 138 [patent_figures_cnt] => 138 [patent_no_of_words] => 27960 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182937.pdf [firstpage_image] =>[orig_patent_app_number] => 13011798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487404 [patent_doc_number] => 20110236376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'NON-NEUTRALIZING IMMUNITY TO INFLUENZA TO PREVENT SECONDARY BACTERIAL PNEUMONIA' [patent_app_type] => utility [patent_app_number] => 13/010317 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 17925 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236376.pdf [firstpage_image] =>[orig_patent_app_number] => 13010317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652876 [patent_doc_number] => 08372622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Modified vaccinia virus ankara for the vaccination of neonates' [patent_app_type] => utility [patent_app_number] => 13/006824 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17634 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13006824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159525 [patent_doc_number] => 20110158984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'ANTI-ORTHOPOXVIRUS RECOMBINANT POLYCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/965437 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 24140 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20110158984.pdf [firstpage_image] =>[orig_patent_app_number] => 12965437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936032 [patent_doc_number] => 20110212129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Method for Producing the Flu Virus' [patent_app_type] => utility [patent_app_number] => 12/962375 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14150 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212129.pdf [firstpage_image] =>[orig_patent_app_number] => 12962375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070167 [patent_doc_number] => 20110045017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'HIV VACCINE FOR MUCOSAL DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/941176 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9183 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045017.pdf [firstpage_image] =>[orig_patent_app_number] => 12941176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953138 [patent_doc_number] => 20110033840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'VIRAL DETECTION LIPOSOMES AND METHOD' [patent_app_type] => utility [patent_app_number] => 12/906475 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4773 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033840.pdf [firstpage_image] =>[orig_patent_app_number] => 12906475 [rel_patent_id] =>[rel_patent_doc_number] =>)